These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7248039)

  • 21. [Comparative in vitro dissolution studies of piroxicam suppositories using the basket, the paddle and the flow through methods].
    Horváth G; Nagy K
    Acta Pharm Hung; 1994 Jul; 64(4):135-40. PubMed ID: 7976368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Availability of oxyphenbutazone from different suppository formulations.
    Ibrahim SA; Abd Elbary A; Elsorady H; Abd Elmonem H
    Pharmazie; 1980; 35(4):213-6. PubMed ID: 7403242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Stability of aminophenazone anal suppositories prepared with selected hydrophobic bases].
    Kosior A
    Ann Univ Mariae Curie Sklodowska Med; 1982; 37():219-25. PubMed ID: 6927069
    [No Abstract]   [Full Text] [Related]  

  • 24. [Dissolution of aminophenazon from anal suppositories -- investigated in vitro (author's transl)].
    Kosior A
    Ann Univ Mariae Curie Sklodowska Med; 1979; 34():65-9. PubMed ID: 262156
    [No Abstract]   [Full Text] [Related]  

  • 25. [Evaluation of the method of assaying glucose in vaginal suppositories].
    Pasich J
    Acta Pol Pharm; 1966; 23(3):243-6. PubMed ID: 5913838
    [No Abstract]   [Full Text] [Related]  

  • 26. [Characterization of storage-induced release reductions in suppositories (author's transl)].
    Voigt R; Grohmann A; Bornschein M
    Pharmazie; 1981 Sep; 36(9):631-3. PubMed ID: 7301905
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The solubility of drugs in lipoid vehicles].
    Pflegel P; Klaus T; Schöbel H; Gruno M
    Pharmazie; 1993 Oct; 48(10):741-4. PubMed ID: 8265709
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction of solubility curves and melting properties of organic and pharmaceutical compounds.
    Nordström FL; Rasmuson AC
    Eur J Pharm Sci; 2009 Feb; 36(2-3):330-44. PubMed ID: 19022383
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparison of in vitro model examinaitons with respect to drug release from suppositories].
    Regdon G; Vágó I; Mándi E; Regdon G; Erós I
    Acta Pharm Hung; 2000 Apr; 70(2):45-51. PubMed ID: 11192740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The melting point of suppositories; device for testing the resistance of fatty-base suppositories to deformation.
    REZNEK S
    J Am Pharm Assoc Am Pharm Assoc; 1956 Apr; 45(4):246-8. PubMed ID: 13319101
    [No Abstract]   [Full Text] [Related]  

  • 31. [On the stability of phenylbutazone in suppositories. 1].
    Homann T; Schneidewind G
    Pharmazie; 1982 Oct; 37(10):733. PubMed ID: 7178219
    [No Abstract]   [Full Text] [Related]  

  • 32. Determination of diclofenac released from suppositories using UV spectrophotometry, spectra derivative spectrophotometry and HPLC.
    Sznitowska M; Stokrocka M
    Acta Pol Pharm; 2007; 64(5):401-5. PubMed ID: 18540158
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A prospective randomized placebo-controlled double-blinded pilot study of misoprostol rectal suppositories in the prevention of acute and chronic radiation proctitis symptoms in prostate cancer patients.
    Khan AM; Birk JW; Anderson JC; Georgsson M; Park TL; Smith CJ; Comer GM
    Am J Gastroenterol; 2000 Aug; 95(8):1961-6. PubMed ID: 10950043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Variation in contents of suppositories].
    Fontani F; Setnikar I
    Boll Chim Farm; 1970 Aug; 109(8):447-53. PubMed ID: 5502284
    [No Abstract]   [Full Text] [Related]  

  • 35. Liquefaction times of fatty-type suppositories with and without progesterone.
    Fulper LD; Cleary RW; Harland EC; Hikal AH; Jones AB
    Am J Hosp Pharm; 1990 Mar; 47(3):602-3. PubMed ID: 2316546
    [No Abstract]   [Full Text] [Related]  

  • 36. [Acetaminophen-containing suppositories in vitro and in vivo].
    Regdon G; Szikszay M; Gebri G; Regdon G
    Acta Pharm Hung; 1994 Mar; 64(2):45-9. PubMed ID: 8017207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Swelling, melting point reduction and solubility of PEG 1500 in supercritical CO2.
    Pasquali I; Comi L; Pucciarelli F; Bettini R
    Int J Pharm; 2008 May; 356(1-2):76-81. PubMed ID: 18294790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Why are some properties more difficult to predict than others? A study of QSPR models of solubility, melting point, and Log P.
    Hughes LD; Palmer DS; Nigsch F; Mitchell JB
    J Chem Inf Model; 2008 Jan; 48(1):220-32. PubMed ID: 18186622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relieving perineal pain after perineorrhaphy by diclofenac rectal suppositories: a randomized double-blinded placebo controlled trial.
    Achariyapota V; Titapant V
    J Med Assoc Thai; 2008 Jun; 91(6):799-804. PubMed ID: 18697376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Biopharmaceutic and technological investigation of vagina suppositories containing brilliant green].
    Dzhavakhiia MSh; Churadze LI; Iavich PA
    Georgian Med News; 2008 May; (158):33-6. PubMed ID: 18560037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.